Understanding how macrophages respond in autoimmune diabetes
Autoimmune Diabetes: Macrophage Responses
['FUNDING_R01'] · WASHINGTON UNIVERSITY · NIH-11010016
This study is looking at how certain immune cells called macrophages help clean up dead cells in the pancreas and might play a role in protecting against type 1 diabetes, with the hope of finding new ways to manage or prevent the disease.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | WASHINGTON UNIVERSITY (nih funded) |
| Locations | 1 site (SAINT LOUIS, UNITED STATES) |
| Trial ID | NIH-11010016 on ClinicalTrials.gov |
What this research studies
This research investigates the role of macrophages in autoimmune diabetes, specifically how they respond to the destruction of insulin-producing beta cells in the pancreas. The study focuses on a process called efferocytosis, where macrophages clear dead cells and potentially regulate the autoimmune response. By examining these macrophage responses, the research aims to uncover mechanisms that could protect against the progression of type 1 diabetes. Patients may benefit from insights that could lead to new therapeutic strategies to manage or prevent this condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with type 1 diabetes or those at risk of developing the condition due to autoimmune factors.
Not a fit: Patients with type 2 diabetes or other non-autoimmune forms of diabetes may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that enhance the body's ability to regulate autoimmune responses, potentially preventing or slowing the progression of type 1 diabetes.
How similar studies have performed: Previous research has shown promising results in understanding macrophage functions in autoimmune conditions, suggesting that this approach may yield valuable insights.
Where this research is happening
SAINT LOUIS, UNITED STATES
- WASHINGTON UNIVERSITY — SAINT LOUIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WAN, XIAOXIAO — WASHINGTON UNIVERSITY
- Study coordinator: WAN, XIAOXIAO
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Autoimmune Diabetes